TARDIVE DYSKINESIA
Clinical trials for TARDIVE DYSKINESIA explained in plain language.
Never miss a new study
Get alerted when new TARDIVE DYSKINESIA trials appear
Sign up with your email to follow new studies for TARDIVE DYSKINESIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for tardive dyskinesia: new drug trial targets stubborn symptoms
Disease control Recruiting nowThis study tests whether valbenazine can reduce involuntary muscle movements in people with tardive dyskinesia who still have symptoms despite prior treatment. About 50 adults with schizophrenia, bipolar disorder, or major depression will take valbenazine for 24 weeks. The goal i…
Matched conditions: TARDIVE DYSKINESIA
Phase: PHASE4 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated May 17, 2026 05:44 UTC
-
Can magnetic pulses calm uncontrollable twitching?
Symptom relief Recruiting nowThis study tests whether a non-invasive brain stimulation technique called rTMS can reduce involuntary movements in people with tardive dyskinesia, a condition caused by long-term use of certain medications. About 62 adults will receive either real or placebo rTMS to see if it sa…
Matched conditions: TARDIVE DYSKINESIA
Phase: NA • Sponsor: Peking University Sixth Hospital • Aim: Symptom relief
Last updated May 17, 2026 05:35 UTC
-
New hope for taming tardive Dyskinesia's twitches?
Symptom relief Recruiting nowThis study tests an experimental drug, NBI-1065890, to see if it can reduce the involuntary movements caused by tardive dyskinesia. About 100 adults with conditions like schizophrenia or bipolar disorder who also have moderate to severe tardive dyskinesia will receive either the …
Matched conditions: TARDIVE DYSKINESIA
Phase: PHASE2 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief
Last updated May 07, 2026 18:40 UTC